BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND NFKB2, ENSG00000077150, LYT10, LYT-10, 4791
11 results:

  • 1. Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line.
    Weiner F; Schille JT; Koczan D; Wu XF; Beller M; Junghanss C; Hewicker-Trautwein M; Murua Escobar H; Nolte I
    BMC Cancer; 2021 Oct; 21(1):1088. PubMed ID: 34625047
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
    Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
    Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. prostate cancer incidence and diagnosis in men with PSA levels >20 ng/ml: is it possible to decrease the number of biopsy cores?
    Ozorak A; Zumrutbas AE; Bingol G; Ozlulerden Y; Ozturk SA
    Aging Male; 2020 Dec; 23(5):893-900. PubMed ID: 31156017
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cytokine Gene Polymorphisms Associated With Symptom Clusters in Oncology Patients Undergoing Radiation Therapy.
    Miaskowski C; Conley YP; Mastick J; Paul SM; Cooper BA; Levine JD; Knisely M; Kober KM
    J Pain Symptom Manage; 2017 Sep; 54(3):305-316.e3. PubMed ID: 28797847
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study.
    Bosso D; Pagliuca M; Sonpavde G; Pond G; Lucarelli G; Rossetti S; Facchini G; Scagliarini S; Cartenì G; Daniele B; Morelli F; Ferro M; Puglia L; Izzo M; Montanaro V; Bellelli T; Vitrone F; De Placido S; Buonerba C; Di Lorenzo G
    Medicine (Baltimore); 2017 Jun; 96(24):e6817. PubMed ID: 28614217
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Regulation of mRNA gene expression of members of the NF-κB transcription factor gene family by angiotensin II and relaxin 2 in normal and cancer prostate cell lines.
    Domińska K; Kowalska K; Matysiak ZE; Płuciennik E; Ochędalski T; Piastowska-Ciesielska AW
    Mol Med Rep; 2017 Jun; 15(6):4352-4359. PubMed ID: 28487955
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tomato paste alters NF-κB and cancer-related mRNA expression in prostate cancer cells, xenografts, and xenograft microenvironment.
    Kolberg M; Pedersen S; Bastani NE; Carlsen H; Blomhoff R; Paur I
    Nutr Cancer; 2015; 67(2):305-15. PubMed ID: 25664890
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers.
    Miaskowski C; Cataldo JK; Baggott CR; West C; Dunn LB; Dhruva A; Merriman JD; Langford DJ; Kober KM; Paul SM; Cooper BA; Aouizerat BE
    Support Care Cancer; 2015 Apr; 23(4):953-65. PubMed ID: 25249351
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evidence of associations between cytokine gene polymorphisms and quality of life in patients with cancer and their family caregivers.
    Alexander K; Cooper B; Paul SM; West C; Yates P; Kober KM; Aouizerat BE; Miaskowski C
    Oncol Nurs Forum; 2014 Sep; 41(5):E267-81. PubMed ID: 25158664
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Transcription factors involved in prostate gland adaptation to androgen deprivation.
    Rosa-Ribeiro R; Nishan U; Vidal RO; Barbosa GO; Reis LO; Cesar CL; Carvalho HF
    PLoS One; 2014; 9(6):e97080. PubMed ID: 24886974
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An overview of cancer of the prostate diagnosis and management in Nigeria: the experience in a Nigerian tertiary hospital.
    Ajape AA; Ibrahim KO; Fakeye JA; Abiola OO
    Ann Afr Med; 2010; 9(3):113-7. PubMed ID: 20710099
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.